Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Exploring the Effects of Non-ablative Er:YAG Laser on Patients Suffering From Recurrent Vulvovaginal Candidiasis
INTERVENTIONAL
Inicio: 3 de ene de 2019
ID: NCT06572488
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Study With Asunaprevir and Daclatasvir (DUAL) for Null or Partial Responders to Peginterferon Alfa and Ribavirin (P/R), Intolerant or Ineligible to P/R Subjects and Treatment-Naive Subjects With Chronic Hepatitis C Genotype 1b Infection
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01581203
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double Blind, Double Dummy, Parallel Group, Active Controlled Trial to Evaluate the Antiviral Efficacy of 400 mg QD neVirapine Extended Release Formulation in Comparison to 200 mg BID neVirapinE Immediate Release in Combination With Truvada® in Antiretroviral Therapy naïve HIV-1 Infected Patients (VERxVE)
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00561925
Reclutando
Fase 3
ClinicalTrials.gov
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE IBUZATRELVIR IN ADULTS WITH SYMPTOMATIC COVID-19 WHO ARE SEVERELY IMMUNOCOMPROMISED
INTERVENTIONAL
Inicio: 14 de jul de 2025
ID: NCT07013474
Completado
Fase 2
ClinicalTrials.gov
A Proof of Concept Study for GSK2248761 (An Extension of NV-05A-002: A Phase I/IIa Double-Blind Study to Evaluate the Safety and Tolerability, Antiretroviral Activity, Pharmacokinetics and Pharmacodynamics of IDX12899 in Antiretroviral Treatment-Naive HIV-1 Infected Subjects, Completed by Idenix)
INTERVENTIONAL
Inicio: 20 de oct de 2009
ID: NCT00945282
Completado
ClinicalTrials.gov
A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in Which Peginterferon Lambda-1a (BMS-914143) Was Administered for the Treatment of Chronic Hepatitis C
OBSERVATIONAL
Inicio: 1 de mar de 2012
ID: NCT01525810
Desconocido
ClinicalTrials.gov
Liver Injury in Hospitalized Patients With COVID-19 in Latin America: Clinical Characteristics and Prognostic Factors
OBSERVATIONAL
Inicio: 15 de abr de 2020
ID: NCT04358380
Desconocido
Fase 3
ClinicalTrials.gov
Study to Evaluate the Safety and Effectiveness of an Immunobiological Drug (Anti SARS-CoV-2) in the Treatment of Coronavirus Disease 2019 (CoViD-19)
INTERVENTIONAL
Inicio: 1 de jun de 2021
ID: NCT04913779
Completado
ClinicalTrials.gov
Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2
OBSERVATIONAL
Inicio: 10 de mar de 2020
ID: NCT04174313
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis.
INTERVENTIONAL
Inicio: 11 de nov de 2020
ID: NCT04583423
Completado
ClinicalTrials.gov
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
OBSERVATIONAL
Inicio: 18 de dic de 2006
ID: NCT00388674
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-Blind, Placebo-controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects With Liver Biopsy Proven Non-alcoholic Steatohepatitis (NASH) (ARGON-2)
INTERVENTIONAL
Inicio: 27 de ene de 2020
ID: NCT04378010
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Adults With COVID-19
INTERVENTIONAL
Inicio: 18 de mar de 2021
ID: NCT04705597
Desconocido
Fase 4
ClinicalTrials.gov
Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2)
INTERVENTIONAL
Inicio: 1 de jun de 2020
ID: NCT04530578
Reclutando
ClinicalTrials.gov
Post Authorization Study to Monitor Efficacy, Effectiveness, and Safety of Maribavir (LIVTENCITY®) in Patients With Post-transplant Cytomegalovirus (CMV) Infection in Argentina
OBSERVATIONAL
Inicio: 3 de sept de 2024
ID: NCT06213974
Completado
Fase 3
ClinicalTrials.gov
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) Versus Placebo in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
INTERVENTIONAL
Inicio: 30 de jun de 2010
ID: NCT01079806
Completado
Fase 3
ClinicalTrials.gov
PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial
INTERVENTIONAL
Inicio: 14 de ago de 2020
ID: NCT04460651
Terminado
Fase 1
ClinicalTrials.gov
A Phase 1b, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With RSV Infection
INTERVENTIONAL
Inicio: 4 de dic de 2015
ID: NCT02593851
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01499277
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Randomised, Double-blind, Dose-ranging Study of AVX754 Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V Mutation in Reverse Transcriptase
INTERVENTIONAL
Inicio: 1 de jul de 2005
ID: NCT00126880
Anterior
1
...
39
40
41
...
434
Siguiente
Filtros